Reproductive Factors and Breast Cancer Prognosis: The Possible Role of Cesarean Delivery

Objective: To evaluate the possible associations between tumor pathological characteristics and reproductive factors in women with breast cancer, including method of child delivery. Materials and Methods: Patients diagnosed as breast cancer between January 2012 and April 2013 in Ankara University Hospitals who had at least one full term pregnancy were included. Data upon pathological prognostic features of tumors and reproductive history of patients were obtained from patient files. Results: 434 patients with breast cancer were included. Mean age at the time of breast cancer diagnosis was 49.2±10.7 years. History of at least one cesarean delivery was present in 17% of the patients (n=75). Axillary lymph node positivity was related to younger age at first full-term pregnancy (p=0.018), and higher number of parities (p=0.001) in estrogen receptor positive (ER+) breast cancer patients. Although extracapsular invasion was related to shorter time interval since last parity to cancer diagnosis in the whole population (p=0.029), this association disappeared when patients were categorized according to ER status. However, in ER+ patients, history of cesarean delivery was associated with extracapsular invasion (p=0.023). Also, our findings indicated that patients with history of cesarean delivery were diagnosed with breast cancer at younger ages, and after a shorter time interval since last parity (p

PDF

___

[1]DeSantis CE, Ma J, Gaudet MM, et al. Breast cancer statistics, 2019. CA Cancer J Clin. 2019;69(6):438-51. Epub 2019/10/03.

[2]World Health Organization. Breast Cancer: Prevention and Control. Access Date: 2021/01/20 https://www.who.int/cancer/detection/breastcancer/en/#:~:text=Introduction,and%20adoption%20of%20western%20lifestyles.

[3]Bastiaannet E, Liefers GJ, de Craen AJ, et al. Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients. Breast Cancer Res Treat. 2010;124(3):801-7. Epub 2010/04/30.

[4]Oven Ustaalioglu BB, Bilici A, Kefeli U, et al. Does the metastatic lymph node ratio influence the disease-free survival of patients with breast cancer: single-center experiences. Oncology. 2010;79(1-2):105-11. Epub 2010/11/23.

[5]de Boer M, van Dijck JA, Bult P, et al. Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases. J Natl Cancer Inst. 2010;102(6):410-25. Epub 2010/03/02.

[6]Zhao S, Ma D, Xiao Y, et al. Clinicopathologic features and prognoses of different histologic types of triple-negative breast cancer: A large population-based analysis. Eur J Surg Oncol. 2018;44(4):420-8. Epub 2018/02/13.

[7]Rakha EA, Martin S, Lee AH, et al. The prognostic significance of lymphovascular invasion in invasive breast carcinoma. Cancer. 2012;118(15):3670-80. Epub 2011/12/20.

[8]National Cancer Institute. Breast Cancer Prevention (PDQ): Health Professional Version. Access Date: 2021/01/20 https://www.cancer.gov/types/breast/hp/breast-prevention-pdq#_558.

[9]Ghafouri-Fard S, Taheri M, Omrani MD, et al. Expression of long noncoding RNAs in breast cancer in relation to reproductive factors and tumor characteristics. J Cell Biochem. 2019;120(8):13965-73. Epub 2019/04/09.

[10]McCullough LE, Collin LJ, Conway K, et al. Reproductive characteristics are associated with gene-specific promoter methylation status in breast cancer. BMC Cancer. 2019;19(1):926. Epub 2019/09/20.

[11]Orgeas CC, Hall P, Rosenberg LU, et al. The influence of menstrual risk factors on tumor characteristics and survival in postmenopausal breast cancer. Breast Cancer Res. 2008;10(6):R107. Epub 2008/12/18.

[12]Albrektsen G, Heuch I, Thoresen S, et al. Clinical stage of breast cancer by parity, age at birth, and time since birth: a progressive effect of pregnancy hormones? Cancer Epidemiol Biomarkers Prev. 2006;15(1):65-9. Epub 2006/01/26.

[13]Alsaker MD, Opdahl S, Asvold BO, et al. The association of reproductive factors and breastfeeding with long term survival from breast cancer. Breast Cancer Res Treat. 2011;130(1):175-82. Epub 2011/05/10.

[14]Alsaker MD, Opdahl S, Romundstad PR, et al. Association of time since last birth, age at first birth and parity with breast cancer survival among parous women: a register-based study from Norway. Int J Cancer. 2013;132(1):174-81. Epub 2012/04/19.

[15]Butt S, Borgquist S, Anagnostaki L, et al. Parity and age at first childbirth in relation to the risk of different breast cancer subgroups. Int J Cancer. 2009;125(8):1926-34. Epub 2009/07/02.

[16]Li CI, Beaber EF, Tang MT, et al. Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age. Breast Cancer Res Treat. 2013;137(2):579-87. Epub 2012/12/12.

[17]Phillips KA, Milne RL, West DW, et al. Prediagnosis reproductive factors and all-cause mortality for women with breast cancer in the breast cancer family registry. Cancer Epidemiol Biomarkers Prev. 2009;18(6):1792-7. Epub 2009/06/10.

[18]Trivers KF, Gammon MD, Abrahamson PE, et al. Association between reproductive factors and breast cancer survival in younger women. Breast Cancer Res Treat. 2007;103(1):93-102. Epub 2006/09/28.

[19]Minami Y, Nishino Y, Kawai M, et al. Reproductive history and breast cancer survival: a prospective patient cohort study in Japan. Breast Cancer. 2019. Epub 2019/04/18.

[20]Kalan I, Turgut D, Aksoy S, et al. Clinical and pathological characteristics of breast cancer patients with history of cesarean delivery. Breast. 2010;19(1):67-8. Epub 2009/11/17.

[21]Dawood MY, Wang CF, Gupta R, et al. Fetal contribution to oxytocin in human labor. Obstet Gynecol. 1978;52(2):205-9. Epub 1978/08/01.

[22]Kuwabara Y, Takeda S, Mizuno M, et al. Oxytocin levels in maternal and fetal plasma, amniotic fluid, and neonatal plasma and urine. Arch Gynecol Obstet. 1987;241(1):13-23. Epub 1987/01/01.

[23]Marchini G, Lagercrantz H, Winberg J, et al. Fetal and maternal plasma levels of gastrin, somatostatin and oxytocin after vaginal delivery and elective cesarean section. Early Hum Dev. 1988;18(1):73-9. Epub 1988/11/01.

[24]Copland JA, Jeng YJ, Strakova Z, et al. Demonstration of functional oxytocin receptors in human breast Hs578T cells and their up-regulation through a protein kinase C-dependent pathway. Endocrinology. 1999;140(5):2258-67. Epub 1999/04/28.

[25]Cassoni P, Sapino A, Fortunati N, et al. Oxytocin inhibits the proliferation of MDA-MB231 human breast-cancer cells via cyclic adenosine monophosphate and protein kinase A. Int J Cancer. 1997;72(2):340-4. Epub 1997/07/17.

[26]Cassoni P, Sapino A, Negro F, et al. Oxytocin inhibits proliferation of human breast cancer cell lines. Virchows Arch. 1994;425(5):467-72. Epub 1994/01/01.

[27]Abubakar M, Sung H, Bcr D, et al. Breast cancer risk factors, survival and recurrence, and tumor molecular subtype: analysis of 3012 women from an indigenous Asian population. Breast Cancer Res. 2018;20(1):114. Epub 2018/09/20.

[28]Rosato V, Bosetti C, Negri E, et al. Reproductive and hormonal factors, family history, and breast cancer according to the hormonal receptor status. Eur J Cancer Prev. 2014;23(5):412-7. Epub 2013/07/03.

[29]Song N, Choi JY, Sung H, et al. Tumor subtype-specific associations of hormone-related reproductive factors on breast cancer survival. PLoS One. 2015;10(4):e0123994. Epub 2015/04/16.

[30]Barnett GC, Shah M, Redman K, et al. Risk factors for the incidence of breast cancer: do they affect survival from the disease? J Clin Oncol. 2008;26(20):3310-6. Epub 2008/07/10.

[31]Schouten LJ, Hupperets PS, Jager JJ, et al. Prognostic significance of etiological risk factors in early breast cancer. Breast Cancer Res Treat. 1997;43(3):217-23. Epub 1997/05/01.

[32]Connor AE, Visvanathan K, Baumgartner KB, et al. Pre-diagnostic breastfeeding, adiposity, and mortality among parous Hispanic and non-Hispanic white women with invasive breast cancer: the Breast Cancer Health Disparities Study. Breast Cancer Res Treat. 2017;161(2):321-31. Epub 2016/11/12.

[33]Pathak DR. Dual effect of first full term pregnancy on breast cancer risk: empirical evidence and postulated underlying biology. Cancer Causes Control. 2002;13(4):295-8. Epub 2002/06/21.

[34]Loof-Johanson M, Brudin L, Sundquist M, et al. Breastfeeding and prognostic markers in breast cancer. Breast. 2011;20(2):170-5. Epub 2010/09/21.

[35]Anderson TJ, Ferguson DJ, Raab GM. Cell turnover in the “resting” human breast: influence of parity, contraceptive pill, age and laterality. Br J Cancer. 1982;46(3):376-82. Epub 1982/09/01.

[36]Muenst S, Mechera R, Daster S, et al. Pregnancy at early age is associated with a reduction of progesterone-responsive cells and epithelial Wnt signaling in human breast tissue. Oncotarget. 2017;8(14):22353-60. Epub 2017/04/21.

[37]Zhang JY, Wang MX, Wang X, et al. Associations of reproductive factors with breast cancer prognosis and the modifying effects of menopausal status. Cancer Med. 2020;9(1):385-93. Epub 2019/11/15.

[38]Lambe M, Hsieh C, Trichopoulos D, et al. Transient increase in the risk of breast cancer after giving birth. N Engl J Med. 1994;331(1):5-9. Epub 1994/07/07.

[39]Liu Q, Wuu J, Lambe M, et al. Transient increase in breast cancer risk after giving birth: postpartum period with the highest risk (Sweden). Cancer Causes Control. 2002;13(4):299-305. Epub 2002/06/21.

[40]Gnerlich JL, Deshpande AD, Jeffe DB, et al. Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease. J Am Coll Surg. 2009;208(3):341-7. Epub 2009/03/26.

[41]Balakrishnan N, Teo SH, Sinnadurai S, et al. Impact of Time Since Last Childbirth on Survival of Women with Premenopausal and Postmenopausal Breast Cancers. World J Surg. 2017;41(11):2735-45. Epub 2017/06/28.

[42]De Mulder H, Laenen A, Wildiers H, et al. Breast cancer subtype and survival by parity and time since last birth. Breast Cancer Res Treat. 2018;169(3):481-7. Epub 2018/02/11.